Showing results (271-280 of 855) with videos related to
Sort By:
Pageof 86
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantationPiero Ruggenenti, Igor Codreanu, Paolo Cravedi, et al.Journal of Clinical Pharmacology|June 4, 2009
Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimenDario Cattaneo, Monica Cortinovis, Sara Baldelli, et al.La Medicina Del Lavoro|June 13, 2023
Excess Total Mortality in Italy: An Update to February 2023 with Focus on Working AgesGianfranco Alicandro, Alberto Giovanni Gerli, Stefano Centanni, et al.Transplantation|October 8, 2005
Cyclosporine formulation and Kaposi's sarcoma after renal transplantationDario Cattaneo, Eliana Gotti, Norberto Perico, et al.Scientific Reports|March 22, 2018
Early and late scanning electron microscopy findings in diabetic kidney diseaseSara Conti, Norberto Perico, Rubina Novelli, et al.American Journal of Physiology. Renal Physiology|November 28, 2002
Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2Jawed Alam, Erin Killeen, Pengfei Gong, et al.The Journal of Biological Chemistry|February 27, 2004
A novel angiotensin II type 1 receptor-associated protein induces cellular hypertrophy in rat vascular smooth muscle and renal proximal tubular cellsDeng-Fu Guo, Valerie Tardif, Karin Ghelima, et al.Pediatric Nephrology (Berlin, Germany)|March 16, 2007
Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loopShao-Ling Zhang, Yun-Wen Chen, Stella Tran, et al.Journal of the American Society of Nephrology : JASN|April 7, 2000
CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograftSusanna Tomasoni, Nadia Azzollini, Federica Casiraghi, et al.American Journal of Nephrology|April 22, 2011
Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort studyPaolo Cravedi, Maria Chiara Sghirlanzoni, Maddalena Marasà, et al.Pageof 86